Back to search
FDAFDA · Food and drugs·Recall number D-0862-2017

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

Published May 31, 2017 · Recall initiated: April 21, 2017

Summary

FDA records drug Class I recall D-0862-2017, published May 31, 2017 and initiated April 21, 2017. Recalling firm: Hospira Inc.; Status: Ongoing; Reported quantity: 71,550 syringes; Lot: Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: human hair found within an internal sample syringe.

What to do

Voluntary: Firm initiated · Press Release

Get an email if DEXTROSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEXTROSE
Manufacturer
Hospira Inc.
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10 recalled?

Yes. FDA published recall D-0862-2017 on May 31, 2017. Reported hazard: Presence of Particulate Matter: human hair found within an internal sample syringe.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEXTROSE.